consecutive
patients
treated with
high-dose
Ara-C
lymphomas
institution
syndrome
perfusion
characterized
onset of
fever
diarrhea
shock
pulmonary edema
acute renal failure
metabolic acidosis
weight gain
leukocytosis
bacteriological screening
evidence
infection
Sequential
biological assays
IL-1
IL-2
TNF
PAF
Ara-C
infusion
patients
syndrome
TNF
PAF
activity
serum
cases
controls
TNF
PAF
development
septic shock
adult
respiratory distress syndrome
high-dose
Ara-C
associated with
cytokine release
